Piet Habbel
- Co-authors
- Lindsey A. VandergriftLeo L. ChengJohannes NowakDavid KaulIgor A. KaltashovKarsten H. WeylandtJing X. KangJan Eucker
- Topics
- Metabolomics and Mass Spectrometry Studies (10 papers)Mass Spectrometry Techniques and Applications (3 papers)Venous Thromboembolism Diagnosis and Management (3 papers)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Piet Habbel
27 papers receiving 810 citations
Peers
Comparison fields: 5 of 105
- Molecular Biology 378
- Cancer Research 147
- Immunology 119
- Oncology 116
- Epidemiology 92
Countries citing papers authored by Piet Habbel
This map shows the geographic impact of Piet Habbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piet Habbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piet Habbel more than expected).
Fields of papers citing papers by Piet Habbel
This network shows the impact of papers produced by Piet Habbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piet Habbel. The network helps show where Piet Habbel may publish in the future.
Co-authorship network of co-authors of Piet Habbel
This figure shows the co-authorship network connecting the top 25 collaborators of Piet Habbel. A scholar is included among the top collaborators of Piet Habbel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piet Habbel. Piet Habbel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 23 | |
| 6 | 3 | |
| 7 | 129 | |
| 8 | 21 | |
| 9 | 24 | |
| 10 | 22 | |
| 11 | 26 | |
| 12 | 15 | |
| 13 | TKI258, a multi-tyrosine kinase inhibitor is efficacious against human infant/childhood lymphoblastic leukemia in vitro. | 4 |
| 14 | 36 | |
| 15 | The multi-tyrosine kinase inhibitor TKI258, alone or in combination with RAD001, is effective for treatment of human leukemia with BCR-ABL translocation in vitro. | 5 |
| 16 | 107 | |
| 17 | 53 | |
| 18 | 10 | |
| 19 | 31 | |
| 20 | 84 |
About Piet Habbel
Piet Habbel is a scholar working on Internal Medicine, Spectroscopy and Genetics, having authored 29 papers that have together received 817 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (10 papers), Mass Spectrometry Techniques and Applications (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). The work is most often cited by research in Biological Psychiatry (26 citations), Cancer Research (147 citations) and Neurology (67 citations). Piet Habbel has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Lindsey A. Vandergrift, Leo L. Cheng, Johannes Nowak, David Kaul, Igor A. Kaltashov, Karsten H. Weylandt, Jing X. Kang, Jan Eucker, Katja Derkow and Seija Lehnardt. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.